首页> EBioMedicine> Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes.

Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes.

导出 LinkOut

翻译打印收藏纠错

第一作者： Maria R,Jimenez-Leon

第一单位： Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, CSIC, University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain.

作者： Maria R,Jimenez-Leon ^[1] ; Carmen,Gasca-Capote ^[1] ; Laura,Tarancon-Diez ^[2] ; Beatriz,Dominguez-Molina ^[1] ; Macarena,Lopez-Verdugo ^[1] ; Ryan,Ritraj ^[3] ; Isabel,Gallego ^[1] ; Ana I,Alvarez-Rios ^[4] ; Joana,Vitalle ^[1] ; Sara,Bachiller ^[1] ; María Inés,Camacho-Sojo ^[1] ; Alberto,Perez-Gomez ^[1] ; Nuria,Espinosa ^[1] ; Cristina,Roca-Oporto ^[1] ; Mohamed,Rafii-El-Idrissi Benhnia ^[5] ; Alicia,Gutierrez-Valencia ^[1] ; Luis F,Lopez-Cortes ^[1] ; Ezequiel,Ruiz-Mateos ^[6]

作者单位： Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, CSIC, University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain. ^[1] Immunology Section, Laboratorio InmunoBiología Molecular (LIBM), Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Area of Immune System Pathology, Madrid, Spain. ^[2] Harvard Medical School, Boston, MA, USA. ^[3] Department of Clinical Biochemistry, Virgen del Rocío University Hospital, CSIC, University of Seville, Seville, Spain. ^[4] Department of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, University of Seville, Seville, Spain. ^[5] Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, CSIC, University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain. Electronic address: Eruizmateos-ibis@us.es. ^[6]

关键词 HIV-1 restriction factors and immunotherapy HIV-Infection Plasmacytoid dendritic cells TLR agonists

医学主题词 Toll样受体9(Toll-Like Receptor 9);树突细胞(Dendritic Cells);细胞因子类(Cytokines);佐剂, 免疫(Adjuvants, Immunologic);表型(Phenotype)

DOI 10.1016/j.ebiom.2023.104549

PMID 37018973

发布时间 2023-05-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

EBioMedicine

2023年91卷

104549页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

EBioMedicine

2023年91卷

104549页

检索历史清除

Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes.

EBioMedicine

相似文献

同项目论文

EBioMedicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes.

EBioMedicine

相似文献

同项目论文

EBioMedicine

相关期刊

检索历史清除